SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Lancaster Colony Corporation (LANC) trades at a trailing P/E of 28.5, forward P/E of 24.5. Trailing earnings yield is 3.51%, forward earnings yield 4.09%. PEG 5.27.
Criteria proven by this page:
- VALUE (68/100, Pass) — analyst target implies upside (+25%).
- Forward P/E 24.5 (down from trailing 28.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 5.27 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 3.51% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.09% as earnings recover.
- Analyst consensus target $216.00 (+25% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 69/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
68/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LANC
Valuation Multiples
P/E (TTM)28.5
Forward P/E24.5
PEG Ratio5.27
Forward PEG1.49
P/B Ratio0.00
P/S Ratio2.49
EV/EBITDA0.0
Per Share Data
EPS (TTM)$6.07
Forward EPS (Est.)$7.07
Book Value / Share$0.00
Revenue / Share$69.45
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.51%
Forward Earnings Yield4.09%
Dividend Yield0.00%
Analyst Target$216.00 (+25%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.44 |
$1.19B |
$121.76M |
10.2% |
| 2017 |
$4.20 |
$1.2B |
$115.31M |
9.6% |
| 2018 |
$4.93 |
$1.22B |
$135.31M |
11.1% |
| 2019 |
$5.47 |
$1.31B |
$150.55M |
11.5% |
| 2020 |
$4.97 |
$1.33B |
$136.98M |
10.3% |
| 2021 |
$5.16 |
$1.47B |
$142.33M |
9.7% |
| 2022 |
$3.25 |
$1.68B |
$89.59M |
5.3% |
| 2023 |
$4.04 |
$1.82B |
$111.29M |
6.1% |
| 2024 |
$5.76 |
$1.87B |
$158.61M |
8.5% |
| 2025 |
$6.07 |
$1.91B |
$167.35M |
8.8% |
